CA
IMCR icon

CoreCap Advisors’s Immunocore IMCR Stock Holding History

CoreCap Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$857 Hold
27
– – ﹤0.01% 2733
2026
Q1 		$814 Hold
27
– – ﹤0.01% 2563
2025
Q4 		$937 Buy
+27
New +$953 ﹤0.01% 2613

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

CoreCap Advisors's IMCR Position: Q2 2026 in Review

CoreCap Advisors held its Immunocore (IMCR) position steady in Q2 2026 at 27 shares worth $857. The position accounts for ﹤0.01% of the portfolio, ranked #2733.

CoreCap Advisors first reported a position in IMCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $937 in Q4 2025. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • CoreCap Advisors held 27 shares of Immunocore worth $857 as of Q2 2026.
  • CoreCap Advisors left its Immunocore share count unchanged in Q2 2026.
  • Immunocore made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2733 holding.
  • CoreCap Advisors first reported a position in Immunocore in Q4 2025 and has held it in 3 quarters since.
  • CoreCap Advisors's Immunocore position peaked at $937 in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.